As a type of chemotherapy medicine, Docefrez is prescribed to treat several cancers, including breast cancer, prostate cancer, and non-small cell lung cancer. It works by interfering with the way cancer cells grow. Side effects may include weakness, anemia, and fluid retention. This medication is administered intravenously by your healthcare provider, typically every three weeks.
What Is Docefrez?
Docefrez™ (docetaxel) is a prescription chemotherapy medication that belongs to a class of medicines known as taxanes. It is approved for use alone or in combination with other medicines to treat certain types of cancer. Specifically, Docefrez is approved to treat the following types of cancer:
Docefrez is manufactured by Sun Pharmaceutical Ind., Ltd., for Caraco Pharmaceutical Laboratories, Ltd.
How Does Docefrez Work?
Docefrez belongs to a group of medications called taxanes. Taxanes work by stabilizing certain structures inside cells called microtubules and preventing the cells from breaking them down. Because cells must disassemble microtubules in order to divide and multiply, Docefrez stops cell growth.
Docefrez can kill both healthy and cancerous cells, which is what causes many of the dangerous side effects. However, it has a greater effect on cells that multiply rapidly. In general, cancer cells multiply more rapidly than healthy cells and are, therefore, more affected by treatment.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed March 28, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click